|
|
81 Peachtree Place, Ne Suite Atlanta, GA 30309 USA phone:404 452 1891 fax:678 298 8233
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.sensiotec.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Wireless Monitoring of Vital Signs and Movement |
 |
| Management |
| Robert Arkin, CEO |
| |
|
|
| |
|
| Keywords |
| Health IT, Patient Monitoring, Vital Signs, Remote Monitoring, Chronic Disease Managemen |
|
|
|
| Description |
|
Sensiotec is a development stage company based in Atlanta, Georgia. Sensiotec's value proposition is to commercialize next-generation wireless medical monitoring devices that improves healthcare quality and safety, and reduces costs. |
 |
| Products / Services |
Preventa(TM) monitors heart and respiration rates, bed occupancy and movement on a continuous, real-time, remote basis, "watching" patients 100% of the time from a monitoring station down the hall or even 1,500 miles away. Caregivers gain a disease management tool that can help reduce complications associated with common chronic illnesses (such as heart disease, COPD and sleep apnea), optimize scarce human resources, and reduce hospital admissions and ER visits. Preventa(TM) also alerts caregivers when a patient requires an assisted relocation to help prevent bed sores. Using additional proprietary components, Preventa(TM) tracks roaming physical assets and protects wandering at-risk patients (locking exit doors or elevators automatically).
|
 |
| Technology / Differentiation |
| Preventa(TM) is the first medical device to harness the potential of UWB, an emerging wireless communications standard and former classified military technology, creating a wireless vital signs monitor. In 2002, the FCC authorized the use of UWB for the development of new imaging systems to "see" inside the human body. |
 |
 |
| Status |
| The company announced that its wireless monitor received FDA 510(k) Class II clearance in February 2009. Under the brand name Preventa (TM), Sensiotec will market and sell the medical device in the US and Canada under an exclusive worldwide license with its affiliate, Wireless 2000. Wireless 2000 received the sign off from the FDA's Division of Cardiovascular Devices. |
 |
|
|
|
|
|
|